Worldwide Clinical Trials acquires Catalyst Clinical Research
Worldwide Clinical Trials agreed to acquire Catalyst Clinical Research. Reported deal value: Undisclosed. Status: Pending. Sector: Contract Research Organization (CRO). Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-01-22. Figures and status may change as filings and press coverage update.
Worldwide Clinical Trials to acquire Catalyst Salong Debbarma Thu, January 22, 2026 at 10:59 AM GMT+1 2 min read Worldwide Clinical Trials has entered a definitive agreement to acquire oncology contract research organisation Catalyst Clinical Research
Deal timeline
This transaction is classified in Contract Research Organization (CRO). Figures and status may change as sources update.